On Thursday 4 November, 2021, Oventus Founder and CEO, Dr Chris Hart and President
and COO, John Cox presented an investor update on the September 2021 results
and discussion around a very positive recently published clinical study.
To watch a recording of the webinar and the Q&A session, please click
the link below.